VELTASSA® (patiromer) for oral suspension

Indication and Usage

VELTASSA is indicated for the treatment of hyperkalemia.
Limitation of Use: VELTASSA should not be used as an emergency treatment for life-threatening hyperkalemia because of its delayed onset of action.

Important Safety Information

Contraindications: VELTASSA is contraindicated in patients with a history of a hypersensitivity reaction to VELTASSA or any of its components. Please see additional Important Safety Information Important Safety Information below and full Prescribing Information.

Multiple pharmacy options to fit your patients’ needs


You can prescribe VELTASSA in multiple ways:

Retail Pharmacies VELTASSA K+onnect*
Patients can choose from their familiar pharmacies Get VELTASSA delivered straight to your patients’ home or to your office
Face-to-face interactions with pharmacists Comprehensive support services for patients
Patients with commercial insurance may qualify for a coupon program that could reduce their co-pay to no more than $25 a month
  • Patients enrolled in a government healthcare prescription drug program such as Medicare Part D or Medicaid are not eligible for the $25 co-pay program. This includes the period when patients are in the Medicare Part D coverage gap known as the "donut hole"
  • No print coupon required
  • Savings are automatically applied
Patients with commercial insurance may qualify for a coupon program that could reduce their co-pay to no more than $25 a month
  • Patients enrolled in a government healthcare prescription drug program such as Medicare Part D or Medicaid are not eligible for the $25 co-pay program. This includes the period when patients are in the Medicare Part D coverage gap known as the "donut hole"
  • No print coupon required
  • Savings are automatically applied
Allow your patients to pick up all their medications in one place Auto-refills sent directly to your patients‘ home or to your office
Familiar prescribing with paper script Track your patients’ progress with their prescriptions

*VELTASSA K+onnect does not provide medical advice. Patients should consult a healthcare professional if they have any questions about their health or treatment.

Personalized support services with VELTASSA K+onnect

Patients enrolled through VELTASSA K+onnect will be able to take advantage of personalized support programs, including:

  • Stay-on-Track Program
  • Toll-free support hotline to connect with a dedicated Nurse Advocate
  • Financial assistance options

Patient support services

Learn more

The Starter Rx form can help expedite access to VELTASSA for your patients

Download now
Important Safety Information, including Boxed WARNING

Indication and Usage

VELTASSA is indicated for the treatment of hyperkalemia.

Limitation of Use: VELTASSA should not be used as an emergency treatment for life‑threatening hyperkalemia because of its delayed onset of action.


Important Safety Information

Contraindications: VELTASSA is contraindicated in patients with a history of a hypersensitivity reaction to VELTASSA or any of its components.

Worsening of Gastrointestinal Motility: Avoid use of VELTASSA in patients with severe constipation, bowel obstruction or impaction, including abnormal post‑operative bowel motility disorders, because VELTASSA may be ineffective and may worsen gastrointestinal conditions. Patients with a history of bowel obstruction or major gastrointestinal surgery, severe gastrointestinal disorders, or swallowing disorders were not included in clinical studies.

Hypomagnesemia: VELTASSA binds to magnesium in the colon, which can lead to hypomagnesemia. In clinical studies, hypomagnesemia was reported as an adverse reaction in 5.3% of patients treated with VELTASSA. Approximately 9% of patients in clinical trials developed hypomagnesemia with a serum magnesium value <1.4 mg/dL. Monitor serum magnesium. Consider magnesium supplementation in patients who develop low serum magnesium levels.

Adverse Reactions: The most common adverse reactions (incidence ≥2%) are constipation, hypomagnesemia, diarrhea, nausea, abdominal discomfort and flatulence. Mild to moderate hypersensitivity reactions were reported in 0.3% of patients treated with VELTASSA and included edema of the lips.

Please see full Prescribing Information Prescribing Information The VELTASSA Prescribing Information has been updated to remove the Boxed WARNING for binding to other oral medications. Administer VELTASSA at least 3 hours before or 3 hours after other oral medications. Please see Section 12.3 for detailed drug interactions.
Continue
.